Literature DB >> 27464960

Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: The EGEA study.

Valérie Siroux1, Christian Lupinek2, Yvonne Resch2, Mirela Curin2, Jocelyne Just3, Thomas Keil4, Renata Kiss2, Karin Lødrup Carlsen5, Erik Melén6, Rachel Nadif7, Isabelle Pin8, Ingebjørg Skrindo9, Susanne Vrtala10, Magnus Wickman11, Josep Maria Anto12, Rudolf Valenta2, Jean Bousquet13.   

Abstract

BACKGROUND: The nature of allergens and route and dose of exposure may affect the natural development of IgE and IgG responses.
OBJECTIVE: We sought to investigate the natural IgE and IgG responses toward a large panel of respiratory and food allergens in subjects exposed to different respiratory allergen loads.
METHODS: A cross-sectional analysis was conducted in 340 adults of the EGEA (Epidemiological study of the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy) (170 with and 170 without asthma) cohort. IgE and IgG responses to 47 inhalant and food allergen components were analyzed in sera using allergen microarray and compared between 5 French regions according to the route of allergen exposure (inhaled vs food allergens).
RESULTS: Overall 48.8% of the population had allergen-specific IgE levels of 0.3 ISAC standardized units (ISU) or more to at least 1 of the 47 allergens with no significant differences across the regions. For ubiquitous respiratory allergens (ie, grass, olive/ash pollen, house dust mites), specific IgE did not show marked differences between regions and specific IgG (≥0.5 ISU) was present in most subjects everywhere. For regionally occurring pollen allergens (ragweed, birch, cypress), IgE sensitization was significantly associated with regional pollen exposure. For airborne allergens cross-reacting with food allergens, frequent IgG recognition was observed even in regions with low allergen prevalence (Bet v 1) or for allergens less frequently recognized by IgE (profilins).
CONCLUSIONS: The variability in allergen-specific IgE and IgG frequencies depends on exposure, route of exposure, and overall immunogenicity of the allergen. Allergen contact by the oral route might preferentially induce IgG responses.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EGEA; IgE; IgG; MeDALL; allergen components; cohort; epidemiology; food allergens; microarray; respiratory allergens

Mesh:

Substances:

Year:  2016        PMID: 27464960     DOI: 10.1016/j.jaci.2016.05.023

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

Review 1.  Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?

Authors:  Cezmi A Akdis
Journal:  Nat Rev Immunol       Date:  2021-04-12       Impact factor: 53.106

Review 2.  ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

Authors:  J Bousquet; P W Hellings; I Agache; A Bedbrook; C Bachert; K C Bergmann; M Bewick; C Bindslev-Jensen; S Bosnic-Anticevitch; C Bucca; D P Caimmi; P A M Camargos; G W Canonica; T Casale; N H Chavannes; A A Cruz; G De Carlo; R Dahl; P Demoly; P Devillier; J Fonseca; W J Fokkens; N A Guldemond; T Haahtela; M Illario; J Just; T Keil; L Klimek; P Kuna; D Larenas-Linnemann; M Morais-Almeida; J Mullol; R Murray; R Naclerio; R E O'Hehir; N G Papadopoulos; R Pawankar; P Potter; D Ryan; B Samolinski; H J Schunemann; A Sheikh; F E R Simons; C Stellato; A Todo-Bom; P V Tomazic; A Valiulis; E Valovirta; M T Ventura; M Wickman; I Young; A Yorgancioglu; T Zuberbier; W Aberer; C A Akdis; M Akdis; I Annesi-Maesano; J Ankri; I J Ansotegui; J M Anto; S Arnavielhe; A Asarnoj; H Arshad; F Avolio; I Baiardini; C Barbara; M Barbagallo; E D Bateman; B Beghé; E H Bel; K S Bennoor; M Benson; A Z Białoszewski; T Bieber; L Bjermer; H Blain; F Blasi; A L Boner; M Bonini; S Bonini; I Bosse; J Bouchard; L P Boulet; R Bourret; P J Bousquet; F Braido; A H Briggs; C E Brightling; J Brozek; R Buhl; C Bunu; E Burte; A Bush; F Caballero-Fonseca; M A Calderon; T Camuzat; V Cardona; P Carreiro-Martins; A M Carriazo; K H Carlsen; W Carr; A M Cepeda Sarabia; M Cesari; L Chatzi; R Chiron; T Chivato; E Chkhartishvili; A G Chuchalin; K F Chung; G Ciprandi; J Correia de Sousa; L Cox; G Crooks; A Custovic; S E Dahlen; U Darsow; T Dedeu; D Deleanu; J A Denburg; G De Vries; A Didier; A T Dinh-Xuan; D Dokic; H Douagui; G Dray; R Dubakiene; S R Durham; G Du Toit; M S Dykewicz; P Eklund; Y El-Gamal; E Ellers; R Emuzyte; J Farrell; A Fink Wagner; A Fiocchi; M Fletcher; F Forastiere; M Gaga; A Gamkrelidze; B Gemicioğlu; J E Gereda; R Gerth van Wick; S González Diaz; I Grisle; L Grouse; Z Gutter; M A Guzmán; B Hellquist-Dahl; J Heinrich; F Horak; J O' B Hourihane; M Humbert; M Hyland; G Iaccarino; E J Jares; C Jeandel; S L Johnston; G Joos; O Jonquet; K S Jung; M Jutel; I Kaidashev; M Khaitov; O Kalayci; A F Kalyoncu; P Kardas; P K Keith; M Kerkhof; H A M Kerstjens; N Khaltaev; M Kogevinas; V Kolek; G H Koppelman; M L Kowalski; M Kuitunen; I Kull; V Kvedariene; B Lambrecht; S Lau; D Laune; L T T Le; P Lieberman; B Lipworth; J Li; K C Lodrup Carlsen; R Louis; C Lupinek; W MacNee; Y Magar; A Magnan; B Mahboub; D Maier; I Majer; J Malva; P Manning; E De Manuel Keenoy; G D Marshall; M R Masjedi; E Mathieu-Dupas; M Maurer; S Mavale-Manuel; E Melén; E Melo-Gomes; E O Meltzer; J Mercier; H Merk; N Miculinic; F Mihaltan; B Milenkovic; J Millot-Keurinck; Y Mohammad; I Momas; R Mösges; A Muraro; L Namazova-Baranova; R Nadif; H Neffen; K Nekam; A Nieto; B Niggemann; L Nogueira-Silva; M Nogues; T D Nyembue; K Ohta; Y Okamoto; K Okubo; M Olive-Elias; S Ouedraogo; P Paggiaro; I Pali-Schöll; S Palkonen; P Panzner; A Papi; H S Park; G Passalacqua; S Pedersen; A M Pereira; O Pfaar; R Picard; B Pigearias; I Pin; D Plavec; W Pohl; T A Popov; F Portejoie; D Postma; L K Poulsen; D Price; K F Rabe; F Raciborski; G Roberts; C Robalo-Cordeiro; F Rodenas; L Rodriguez-Mañas; C Rolland; M Roman Rodriguez; A Romano; J Rosado-Pinto; N Rosario; M Rottem; M Sanchez-Borges; J Sastre-Dominguez; G K Scadding; N Scichilone; P Schmid-Grendelmeier; E Serrano; M Shields; V Siroux; J C Sisul; I Skrindo; H A Smit; D Solé; T Sooronbaev; O Spranger; R Stelmach; P J Sterk; T Strandberg; J Sunyer; C Thijs; M Triggiani; R Valenta; A Valero; M van Eerd; E van Ganse; M van Hague; O Vandenplas; L L Varona; B Vellas; G Vezzani; T Vazankari; G Viegi; T Vontetsianos; M Wagenmann; S Walker; D Y Wang; U Wahn; T Werfel; B Whalley; D M Williams; S Williams; N Wilson; J Wright; B P Yawn; P K Yiallouros; O M Yusuf; A Zaidi; H J Zar; M E Zernotti; L Zhang; N Zhong; M Zidarn
Journal:  Clin Transl Allergy       Date:  2016-12-30       Impact factor: 5.871

3.  Amb a 1 isoforms: Unequal siblings with distinct immunological features.

Authors:  M Wolf; T E Twaroch; S Huber; M Reithofer; M Steiner; L Aglas; M Hauser; I Aloisi; C Asam; H Hofer; M A Parigiani; C Ebner; B Bohle; P Briza; A Neubauer; F Stolz; B Jahn-Schmid; M Wallner; F Ferreira
Journal:  Allergy       Date:  2017-06-14       Impact factor: 13.146

4.  Allergy diagnosis from symptoms to molecules, or from molecules to symptoms: a comparative clinical study.

Authors:  N Mothes-Luksch; G Jordakieva; L Hinterhölzl; A N Jensen; P K Hallmann; M Kundi; E Jensen-Jarolim
Journal:  World Allergy Organ J       Date:  2018-09-11       Impact factor: 4.084

5.  Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized mice.

Authors:  Alina Neunkirchner; Bernhard Kratzer; Cordula Köhler; Ursula Smole; Lukas F Mager; Klaus G Schmetterer; Doris Trapin; Victoria Leb-Reichl; Edward Rosloniec; Ronald Naumann; Lukas Kenner; Beatrice Jahn-Schmid; Barbara Bohle; Rudolf Valenta; Winfried F Pickl
Journal:  EBioMedicine       Date:  2018-04-05       Impact factor: 8.143

Review 6.  Recombinant allergy vaccines based on allergen-derived B cell epitopes.

Authors:  Rudolf Valenta; Raffaela Campana; Verena Niederberger
Journal:  Immunol Lett       Date:  2017-05-01       Impact factor: 3.685

7.  Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patients.

Authors:  Raffaela Campana; Katharina Moritz; Angela Neubauer; Hans Huber; Rainer Henning; Tess M Brodie; Alexandra Kaider; Federica Sallusto; Stefan Wöhrl; Rudolf Valenta
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

Review 8.  Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?

Authors:  Inna Tulaeva; Bernhard Kratzer; Raffaela Campana; Mirela Curin; Marianne van Hage; Antonina Karsonova; Ksenja Riabova; Alexander Karaulov; Musa Khaitov; Winfried F Pickl; Rudolf Valenta
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

9.  Determination of IgE and IgG reactivity to more than 170 allergen molecules in paper-dried blood spots.

Authors:  Victoria Garib; Eva Rigler; Felix Gastager; Raffaela Campana; Yulia Dorofeeva; Pia Gattinger; Yury Zhernov; Musa Khaitov; Rudolf Valenta
Journal:  J Allergy Clin Immunol       Date:  2018-11-01       Impact factor: 10.793

10.  Maternal allergen-specific IgG might protect the child against allergic sensitization.

Authors:  Christian Lupinek; Heidrun Hochwallner; Catharina Johansson; Axel Mie; Eva Rigler; Annika Scheynius; Johan Alm; Rudolf Valenta
Journal:  J Allergy Clin Immunol       Date:  2019-01-25       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.